Spanish Red Biotech Pipeline

MSD

Pembrolizumab

Type: Biodrugs/ Drugs
Therapeutic area: Cancer
Indication: First line treatment of recurrent/Metastasic Head and Neck Squamous Cell Carcinoma.
Phase: 3Phase III in Spain, 2Phase II, 1Phase I